Klox Technologies Inc.
Colgate-Palmolive and Klox Technologies Enter Into Agreements for Oral Health
NEW YORK and LAVAL, Quebec, 2016-02-08 14:47 CET (GLOBE NEWSWIRE) --
Colgate-Palmolive Company ("Colgate") and Klox Technologies Inc. ("KLOX") have entered into agreements to globally commercialize and further develop KLOX’s human Oral Health technology platform. The agreements include a worldwide license to commercialize KLOX’s proprietary Biophotonic technology in the field of human Oral Health and an equity investment in KLOX by Colgate.
Dr. Lise Hébert, President and CEO of KLOX, stated: "We are extremely pleased to have Colgate-Palmolive, the leader in Oral Care, with activities in over 200 countries and territories be our global partner for our Oral Health platform. These agreements once again recognize the breadth of our technology platform. Furthermore, these agreements validate the value creation strategy we have adopted by partnering large potential indications with first in class partners, while building a specialized salesforce for products within Wound Care."
Suzan Harrison, President of Global Oral Care of Colgate, stated: "We are very pleased to have KLOX as a partner in the development of this exciting and newtechnology platform for the benefit of Oral Health."
About Colgate-Palmolive Company:
Colgate-Palmolive is a leading global consumer products company, tightly focused on Oral Care, Personal Care, Home Care and Pet Nutrition. Colgate sells its products in over 200 countries and territories around the world under such internationally recognized brand names as Colgate, Palmolive, Speed Stick, Lady Speed Stick, Softsoap, Irish Spring, Protex, Sorriso, Kolynos, elmex, Tom's of Maine, Sanex, Ajax, Axion, Fabuloso, Soupline and Suavitel, as well as Hill's Science Diet, Hill's Prescription Diet and Hill's Ideal Balance. For more information about Colgate's global business, visit the Company's web site athttp://www.colgatepalmolive.com. To learn more about Colgate Bright Smiles, Bright Futures® oral health education program, please visithttp://www.colgatebsbf.com.
About Klox Technologies Inc.:
KLOX is a specialty pharmaceutical company focused on developing and commercializing products based on its proprietary Biophotonic technology platform to address skin and soft tissue disorders. The company has a multi-franchise platform focusing on indications across Dermatology, Wound Care, and Oral Health.
To learn more about KLOX, please visithttp://www.kloxtechnologies.com.
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
Cisco18.1.2018 14:02 | pressemeddelelse
FutureWAN'18 Brings Industry Leaders Together for Global SD-WAN Summit
Renaissance BioScience Corp.18.1.2018 13:01 | pressemeddelelse
Angel Yeast Co., Ltd. signs exclusive global licence agreement with Renaissance BioScience Corp. for wine, cider and craft beer yeast
JD Norman Industries, Inc.18.1.2018 06:02 | pressemeddelelse
JD Norman Industries, Inc. Completes Acquisition of REGE Motorenteile
Aptean17.1.2018 21:01 | pressemeddelelse
Partnership With FAST Technologies Expands Aptean's European Footprint
World Finance17.1.2018 15:30 | pressemeddelelse
Egyptian Steel recognised in the World Finance 100 guide for 2017
European CEO17.1.2018 15:07 | pressemeddelelse
Investing in Berlin's thriving real estate market
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum